Research is indicating that a less efficient metabolic pathway plays a role in DMT’s psychoactivity.
The catalog of compounds for use in psychedelic drug research continues to grow.
The researchers hope these compounds “will expand the universe of options for improving mental health.”
Scientific research does not support his statements that psychedelics are “very potent” and “very dangerous.”
Understanding the pharmacology of magic mushrooms is not just about tryptamines anymore.
Surprisingly, 4-HO-TMT has binding affinity similar to psilocin at 5-HT2A.
Understanding this is more important than ever in psychedelic research because scientists think DMT may be an endogenous neurotransmitter.
Psychedelic Science Review Editor Barb Bauer conducts a review of some landmark studies.
The research will use cutting-edge technology to attempt to remove undesirable side-effects from drugs targeting GPCRs, including the serotonin receptors where psychedelics act.
Researchers are uncovering reasons to think there’s more to DMT than just hallucinations.